MEDICAL ADVOCATES
IDUs
  Hepatitis C

General Reports

Pathogenesis
National Studies
Prevention
Diagnosis/Monitoring/Screening/Testing

Clinical Management
Drugs
HIV/HCV Coinfection

IDU Disease Main Page Main New/Newsworthy  Home Page

Last Update:  April 25, 2018   
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports
       

        Videos

 
HIV and hepatitis C survival in used syringes
 

         Journal Papers, Abstracts, and Commentaries
 

 

 

Outpatient directly observed therapy for hepatitis C among people who use drugs: systematic review and meta-analysis.
McDermott CL, Lockhart CM, Devine B.
J Virus Erad. 2018 Apr 1;4(2):118-122.
Abstract

HIV Serostatus and Having Access to a Physician for Regular Hepatitis C Virus Care Among People Who Inject Drugs.
Beaulieu T, Hayashi K, Milloy MJ,et al
J Acquir Immune Defic Syndr. 2018 May 1;78(1):93-98.
Abstract

Injection-related hepatitis C serosorting behaviors among people who inject drugs: An urban/rural comparison.
Duncan I, Habecker P, Hautala D,  et al

J Ethn Subst Abuse
. 2018 Feb 13:
Abstract

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.
Grebely J, Bruneau J, Lazarus JV,  et al
 Int
J Drug Policy
. 2017 Jul 3.
Abstract

FULL-TEXT ARTICLE
Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response
Elsherif O, Bannan C, Keating S,  e
PLoS One. 2017 Jun 21;12(6):e0178398
Paper

FULL-TEXT ARTICL
Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis.
Davis SM, Daily S, Kristjansson AL,  et al
Harm Reduct J. 2017 May 17;14(1):2
5.
Paper

Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C.
Grebely J, Swan T, Hickman M, Bruneau J, et al
J Hepatol
. 2017 Feb 3.
Abstract

FULL-TEXT ARTICLE
Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis.
Smith DJ, Jordan AE, Frank M, Hagan H.

BMC Infect Dis
. 2016 Sep 5;16:471.
Paper

Chronic hepatitis C infection and the pro-inflammatory effects of injection drug use.
Markowitz M, Deren S, Cleland C,  et al
J Infect Dis
. 2016 Aug 11.
Abstract

Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs.
Weir A, McLeod A, Innes H,  et al
Drug Alcohol Depend
. 2016 May 28.
Abstract

FULL-TEXT ARTICLE
Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.
Ruta S, Cernescu C.

World J Gastroenterol
. 2015 Oct 14;21(38):10811-23.
Paper

Modelling hepatitis C virus transmission among people who inject drugs: assumptions, limitations and future challenges.
Scott N, Hellard M, McBryde E.

Virulence
. 2015 Aug 25:0.
Abstract

Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis.
Smith DJ, Combellick J, Jordan AE, Hagan H.
Int J Drug Policy. 2015 Jul 26. pii: S0955-3959(15)00205-4
Abstract

The promise of treatment as prevention for hepatitis C: Meeting the needs of people who inject drugs?
Harris M, Albers E, Swan T
Int J Drug Policy. 2015 Jun 4
Abstract

Human rights and access to hepatitis C treatment for people who inject drugs.
Wolfe D, Luhmann N, Harris M,
Int J Drug Policy. 2015 Jun 23.

Abstract

Global policy and access to new hepatitis C therapies for people who inject drugs.
Doyle JS, Aspinall EJ, Hutchinson SJ, et al
Int J Drug Policy. 2015 Jun 2.
Abstract

Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.
Cousien A, Tran VC, Deuffic-Burban S,  et al 
J Viral Hepat. 2014 Oct 1
Abstract

Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
Bruggmann P, Grebely J.
Int J Drug Policy. 2014 Aug 30.
Abstract

Risk Factors for HCV Infection Among Young Adults in Rural New York Who Inject Prescription Opioid Analgesics.
Zibbell JE, Hart-Malloy R, Barry J, Fan L, Flanigan C.
Am J Public Health. 2014 Sep 11:e1-e7.
Abstract

FULL-TEXT ARTICLE
Per-Event Probability of Hepatitis C Infection during Sharing of Injecting Equipment.
Boelen L, Teutsch S, Wilson DP, et al

PLoS One
. 2014 Jul 7;9(7):e100749
Paper

Can hepatitis C virus infection be eradicated in people who inject drugs?
Grebely J, Dore GJ.
Antiviral Res. 2014 Jan 24.
Abstract

FULL-TEXT ARTICLE
Hepatitis C transmission and treatment in contact networks of people who inject drugs.

Rolls DA, Sacks-Davis R, Jenkinson R,  et al

PLoS One
. 2013 Nov 1;8(11):e78286
Paper

Hepatitis C infection in non-treatment-seeking heroin users: The burden of cocaine injection.
Roux P, Fugon L, Jones JD, Comer SD.
Am J Addict
. 2013 Nov;22(6):613-8.
Abstract

Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: A longitudinal long-term cohort study
Kielland KB, Delaveris GJ, Rogde S,  et al

J Hepatol
. 2013 Oct 1.
Abstract

Rare occurrence of occult hepatitis C virus in apparently uninfected injecting drug users: a two-centre, masked, case-control study.
Sugden PB, Pham TN, Ratnarajah S,  et al

J Viral Hepat
. 2013 Oct;20(10):725-8.
Abstract

FULL-TEXT ARTICLE
Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review
Mravčík V, Strada L, Stolfa J,  et al
Patient Prefer Adherence. 2013 Oct 17;7:1067-1075.
Paper

The efficiency of targeted intervention in limiting the spread of HIV and Hepatitis C Virus among injecting drug users.
De Vos AS, Kretzschmar ME.
J Theor Biol. 2013 May 31.
Abstract

Control over drug acquisition, preparation and injection: Implications for HIV and HCV risk among young female injection drug users.
Wagner KD, Bloom JJ, Hathazi SD, et al
ISRN Addict. 2013 May 12;2013.
Abstract


A time since onset of injection model for hepatitis C spread amongst injecting drug users.
Corson S, Greenhalgh D, Hutchinson SJ.

J Math Biol
. 2012 Aug 28.
Abstract

Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine.
Grebely J, Prins M, Hellard M,  et al

Lancet Infect Dis
. 2012 May;12(5):408-414
Abstract

Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution.
Liu L, Fisher BE, Thomas DL, et al
Hepatology
. 2012 Jan 11.
Abstract

Meta-Analysis of Hepatitis C Seroconversion in Relation to Shared Syringes and Drug Preparation Equipment.
Pouget ER, Hagan H, Des Jarlais DC.

Addiction
. 2011 Dec 13.
Abstract

Hepatitis C Transmission in Injection Drug Users: Could Swabs Be the Main Culprit?
Thibault V, Bara JL, Nefau T, Duplessy-Garson C.

J Infect Dis
. 2011 Oct 19
Abstract

Mathematically modelling the spread of hepatitis C in injecting drug users.
Corson S, Greenhalgh D, Hutchinson S.

Math Med Biol
. 2011 Sep 6
Abstract

Low risk for hepatitis C seroconversion in methadone maintenance treatment.
Peles E, Schreiber S, Rados V, Adelson M.
J Addict Med. 2011 Sep;5(3):214-20.
Abstract

Multicentric Castleman's Disease in a Hepatitis C-Positive Intravenous Drug User: A Case Report.
Talukder DY, Delpachitra SN.

Case Report Med
. 2011;2011:567840.
Abstract

Chronic pain and hepatitis C virus infection in opioid dependent injection drug users.
Tsui JI, Herman DS, Kettavong M,  et al

J Addict Dis
. 2011 Apr;30(2):91-7
Abstract

Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users.
Paintsil E, He H, Peters C, et al .
J Infect Dis
. 2010 Aug 20
Abstract

Reinfection with hepatitis C virus following sustained virological response in injection drug users.
Grebely J, Knight E, Ngai T, et al
 
J Gastroenterol Hepatol
. 2010 Jul;25(7):1281-1284.
Abstract

Characteristics of chronic hepatitis C among intravenous drug users: a comparative analysis.
Jovanovic M, Jovanovic B, Potic M,
 et al
Bosn J Basic Med Sci
. 2010 May;10(2):153-7.
Abstract


Pathogenesis
       

         Journal Papers, Abstracts, and Commentaries
 
 
Change in hepatitis C virus genotype in injecting drug users.
Aitken C, McCaw R, Jardine D,  
J Med Virol. 2004 Oct 13;74(4):543-545
Abstract 
 

Prevention
       

         Journal Papers, Abstracts, and Commentaries
 
 
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
Platt L, Minozzi S, Reed J, Vickerman P, et al
Cochrane Database Syst Rev. 2017 Sep 18;9:CD012021
Abstract

Modeling Combination HCV Prevention among HIV-infected Men Who Have Sex With Men and People Who Inject Drugs.
Martin NK, Skaathun B, Vickerman P, Stuart D.
AIDS Rev. 2017 May 23;19
Abstract

Impact of Hepatitis C Treatment as Prevention for People Who Inject Drugs is sensitive to contact network structure.
Metzig C, Surey J, Francis M,  et al
Sci Rep. 2017 May 12;7(1):1833.
Abstract

FULL-TEXT ARTICLE
The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
Stone J, Martin NK, Hickman M, et a
l
PLoS One
. 2016 May 25;11(5):e0156213|}|
Paper

Clinicians' Views of Hepatitis C Virus Treatment Candidacy With Direct-Acting Antiviral Regimens for People Who Inject Drugs.
Asher AK, Portillo CJ, Cooper BA,  et al
Subst Use Misuse
. 2016 May 24:1-6.
Abstract

Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication.
Leask JD, Dillon JF.

Aliment Pharmacol Ther
. 2016 May 20.
Abstract

Conditions for eradicating hepatitis C in people who inject drugs: a fibrosis aware model of hepatitis C virus transmission.
Rozada I, Coombs D, Lima VD.

J Theor Biol
. 2016 Feb 1.
Abstract

Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence.
Hickman M, De Angelis D, Vickerman P, et al
Curr Opin Infect Dis
. 2015 Dec;28(6):576-82.
Abstract

Hepatitis c treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs.
Cousien A, Tran VC, Deuffic-Burban S,  et al
Hepatology. 2015 Sep 21
Abstract

Can HIV and HCV Infection be Eliminated among Persons who Inject Drugs?
Perlman DC, Des Jarlais DC, Feelemyer J.

J Addict Dis
. 2015 Jun 15:
Abstract

WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs.
Walsh N, Verster A, Rodolph M, Akl EA.
Int J Drug Policy. 2014 Jan 26.
Abstract

Hepatitis C Virus treatment as prevention among injecting drug users: who should we cure first?
de Vos AS, Prins M, Kretzschmar ME.
Addiction
. 2015 Jan 13.

Abstract

Transitions from injecting to non-injecting drug use: Potential protection against HCV infection.
Des Jarlais DC, McKnight C, Arasteh K,  et al

J Subst Abuse Treat
. 2014 Mar;46(3):325-31
Paper

FULL-TEXT ARTICLE
Hepatitis C avoidance in injection drug users: a typology of possible protective practices.
McGowan C, Harris M, Rhodes T.
PLoS One. 2013 Oct 23;8(10):e77038.
Paper

Hepatitis C virus vaccines among people who inject drugs.
Cox AL, Thomas DL.
Clin Infect Dis. 2013 Aug;57 Suppl 2:S46-50.
Abstract

The efficiency of targeted intervention in limiting the spread of HIV and Hepatitis C Virus among injecting drug users.
De Vos AS, Kretzschmar ME.
J Theor Biol. 2013 May 31.
Abstract

Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: Feasibility and future requirements.
Grebely J, Matthews GV, Lloyd AR, Dore G
J.Clin Infect Dis. 2013 May 31
Abstract

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
Palmateer N, Kimber J, Hickman M,
et al

Addiction
. 2010 Mar 2.
Abstract


Diagnostics/Monitoring/Screening/Testing
       

          Journal Papers, Abstracts, and Commentaries

 
Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: a pilot study.
Fernàndez-López L, Folch C, Majó X, et al   
AIDS Care
. 2016 Mar 23:1-5.
Abstract

Performance of ARCHITECT HCV core antigen test with specimens from US plasma donors and injecting drug users.
Mixson-Hayden T, Dawson GJ,
et al 
J Clin Virol
. 2015 May;66:15-8.
Abstract

A simple strategy to identify acute HCV infection among newly incarcerated injection drug users.
Kim AY, Nagami EH, Birch CE, et al

Hepatology
. 2012 Oct 30.
Abstract

Importance of quick test for screening of former drug users.
Gojak R, Ferhatovic M, Bajramovic

N,Med Arh. 2012;66(3
Suppl 1):30-2.
Abstract


Clinical Management
Drugs      

           Journal Papers, Abstracts, and Commentaries
 

 
FULL-TEXT ARTICLE
The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs
Ti L, Socías ME, Wood E, Milloy MJ,
et al
PLoS One
. 2018 Mar 26;13(3):e0194162
Paper

FULL-TEX ARTICLE
Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.
Akiyama MJ, Agyemang L, Arnsten JH, et al
 
BMC Infect Dis
. 2018 Feb 9;18(1):74.
Paper

Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection.
Artenie AA, Zang G, Daniel M,  et al
Int J Drug Policy. 2017 Jun 3.
Abstract

Recommendations for the management of hepatitis C virus infection among people who inject drugs.
Grebely J, Robaeys G, Bruggmann P, Aghemo A, et al

Int J Drug Policy
. 2015 Jul 17
Abstract

Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience.
Hutchinson SJ, Dillon JF, Fox R,  et al
Int J Drug Policy. 2015 Jun 6.
Abstract

HCV antiviral therapy in injection drug users: difficult to treat or easy to cure?
Persico M, Coppola N, Rosato V,  et al
Ann Hepatol
. 2015 May-jun 2015;14(3):325-332
Abstract

Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users.
Tsui JI, Evans JL, Lum PJ,  et al

JAMA Intern Med
. 2014 Oct 27.
Abstract

FULL-TEXT ARTICLE
Hepatitis C transmission and treatment in contact networks of people who inject drugs.

Rolls DA, Sacks-Davis R, Jenkinson R,  et al

PLoS One
. 2013 Nov 1;8(11):e78286
Paper

Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all.
Bruggmann P, Litwin AH.
Clin Infect Dis. 2013 Aug;57 Suppl 2:S56-61.
Abstract

Treatment of Hepatitis C Virus Infection Among People Who Are Actively Injecting Drugs: A Systematic Review and Meta-analysis.
Aspinall EJ, Corson S, Doyle JS,  et a;
Clin Infect Dis
. 2013 Aug;57 Suppl 2:S80-9
Abstract

Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study.
Alavi M, Grebely J, Micallef M, et al

Clin Infect Dis
. 2013 Aug;57 Suppl 2:S62-9
Abstract

Recommendations for the management of hepatitis C virus infection among people who inject drugs.
Robaeys G, Grebely J, Mauss S, et al
Clin Infect Dis
. 2013 Aug;57 Suppl 2:S129-37.
Abstract

Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: Feasibility and future requirements.
Grebely J, Matthews GV, Lloyd AR, Dore G
J.Clin Infect Dis. 2013 May 31
Abstract

Utility of the Beck Depression Inventory to screen for and track depression in injection drug users seeking hepatitis C treatment.
Holtzheimer PE, Veitengruber J, Wang CC,
et al
Gen Hosp Psychiatry
. 2010 Jul-Aug;32(4):426-32.
Abstract

Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs.
Zeiler I, Langlands T, Murray JM, et al
Drug Alcohol Depend
. 2010 Apr 27
Abstract

 


IDU Disease Main Page Main New/Newsworthy  Home Page

IDU Health: Hepatitis C